| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |